Jiangsu Yutian Pharmaceutical

Jiangsu Yutian Pharmaceutical is a Chinese pharmaceutical company specializing in the research, development, and manufacturing of Active Pharmaceutical Ingredients (APIs), intermediates, and finished dosage forms. Founded in 2009 and headquartered in Lianyungang, the company has established itself as a key player in the fields of contrast agents, inhalation anesthesia, and cardiovascular medicine. Yutian operates high-standard manufacturing facilities that are GMP-certified and provides CDMO/CMO services to global partners. Their product portfolio includes widely used drugs such as Atorvastatin, Ivabradine, and various iodinated contrast media. The company is recognized as a national high-tech enterprise and continues to expand its presence in international markets including Europe, North America, and Asia. Through its subsidiaries and R&D centers, Yutian Pharmaceutical maintains a strong focus on technological innovation and quality management.